G1_Klebsiella_pneumoniae_AJ218_RPMI_vs_G2_Klebsiella_pneumoniae_AJ218_Pooled_sera

Klebsiella_pneumoniae_AJ218_RPMI vs Klebsiella_pneumoniae_AJ218_Pooled_sera

p-value ≤ 0.05 65 significant 2025-09-26 00:00:00 Study: MTBLS2322
126 Total Features
65 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS2322_0001_00000001
Linked study
MTBLS2322 — Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Klebsiella pneumoniae assays)
Comparison
Klebsiella_pneumoniae_AJ218_RPMI vs Klebsiella_pneumoniae_AJ218_Pooled_sera
Group A
Samples of Klebsiella pneumoniae AJ218 grown in RPMI media.. Provides insight into the metabolic profile of Klebsiella pneumoniae AJ218 in RPMI media.
Group B
Samples of Klebsiella pneumoniae AJ218 grown in pooled sera.. Provides insight into the metabolic profile of Klebsiella pneumoniae AJ218 in pooled sera.
Total features tested
126
Significant features
65
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
HVYWMOMLDIMFJA-DPAQBDIFSA-N CHOLESTEROL down 0.01886 0.00139
OVRNDRQMDRJTHS-CBQIKETKSA-N TN antigen saccharide up 14.57 0.00244
CDAISMWEOUEBRE-GPIVLXJGSA-N D-myo-Inositol up 14.45 0.00319
AGPKZVBTJJNPAG-WHFBIAKZSA-N (2<i>S</i>,3<i>S</i>)-2-ammonio-3-methylpentanoate up 3.558 2.11e-05
FFFHZYDWPBMWHY-VKHMYHEASA-N (2S)-2-azaniumyl-4-sulfanylbutanoate up 9.189 0.00277
DTBNBXWJWCWCIK-UHFFFAOYSA-N PEP up 8.86 0.00308
LVRFTAZAXQPQHI-RXMQYKEDSA-N <small>D</small>-2-hydroxy-4-methylvaleric acid up 4.377 0.000265
NGEWQZIDQIYUNV-UHFFFAOYSA-N 3-Methyl-2-hydroxybutyric acid up 4.906 0.000612
XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-Hydroxyphenylacetic acid up 15.94 0.0146
UCMIRNVEIXFBKS-UHFFFAOYSA-N 3-ammoniopropanoate up 9.58 0.00655